The Bionic Bioreactor Company
BioThrust: The first ever solution to controllable & scalable cell therapy manufacturing.
Introducing ComfyCell
A whole new approach to stirred-tank bioreactors for 3D cell therapy manufacturing.
Powered by our unique Membrane Stirrer technology
The BioThrust Membrane Stirrer aerates the cell culture bubble-free & minimizes shear forces with gentle mixing.
Broad Range
Of Applications
Cell Types
83% increase in EVs per mL compared to static control
With THP-1 cells, the 300mL ComfyCell SUB achieved a VCD of 2.19Mn cells/mL (outperforming static culture by 50%) and a EV density of 4.41Bn EVs/mL (outperforming static culture by 83%) - with results confirming stable production of similar EVs.
Cell Types
Viable cell density increased by almost 50%
Human iPSCs were expanded with remarkable success, reaching an impressive expansion factor of 65! Benchmarked against a conventional bioreactor, our system delivered outstanding performance with a threefold increase in total cell numbers, surpassing an incredible 1.6 billion cells!
Cell Types
Successful completion of first human bm-MSC run
Using RoosterBio's human bm-MSC cell line, medium and supplement we were able to confirm expansion with good average viability.
Stay tuned for further updates & publications as we optimize the process!
Cell Types
Impressive >327-fold expansion of iNK cells at 2L
Together with Catalent, iNK cells were expanded in our 300mL SUB and our 2L reusable system, proving the simplicity of upscaling with the ComfyCell. An amazing >327-fold expansion of iNKs (>1000-fold from thaw) while maintaining excellent killing performance confirms the viability of the ComfyCell for commercial iNK production as the only system enabling scales of 10L or more.
Cell Types
Experiments & evaluation ongoing
Stay tuned for further updates & publications
Cell Types
Confirmed 63Mn cells/mL in first high-density perfusion POC
The ComfyCell achieved 63Mn cells/mL in a first proof-of-concept run with HEK293-F cells, maintaining >90% average cell viability without additional optimization strategies. No DO limitations or foaming observed so far.
Stay tuned for further updates & publications as we optimize the process!
Cell Types
Experiments & evaluation ongoing
Stay tuned for further updates & publications
Cell Types
Up to 3mm large organoids cultivated over 35 days in 2L
Compared to conventional runs, our Membrane Stirrer achieved the closest to in-vivo results for iPSC-derived lung organoids our academic partner ever measured, producing up to 3mm large organoids and 100% living cells inside the structure after a process period of 35 days!
Cell Types
More than 35 mn cells/mL without additional oxygen, completely foam free
In a benchmark 10L fed-batch run with a thoroughly optimized conventionally sparged process, the Membrane Stirrer in the first run achieved the same top-notch cell density, but without the need to add any oxygen to the input gas. Furthermore, the usage of anti-foam agents can be completely avoided, since sparging is not required - simplifying handling considerably due to no foam!
Cell Types
More than +200 % increased process yield
Compared to a conventional stirred-tank system, our Membrane Stirrer doubled the achieved cell density and increased production volume by further 30% due to foam avoidance.
Cell Types
Experiments & evaluation ongoing
Stay tuned for further updates & publications
Cell Types
Experiments & evaluation ongoing
Stay tuned for further updates & publications
Process Modalities
Suspension Cells
Leverage the homogeneous, gentle mixing and gas supply of our Membrane Stirrer for a physiological cultivation of your suspension cells (e.g., NK Cells).
Process Modalities
Adherent Cells
Grow your adherent cells (such as MSCs) on microcarriers that are gently kept in motion by the Membrane Stirrer.
Process Modalities
Spheroids (Cell Aggregates)
Manage the size and growth of your three dimensional cell aggregates and spheroids with the precisely controllable shear force induced by the Membrane Stirrer.
Process Modalities
Differentiation Processes
Perform the whole process from cell expansion to differentiation in our ComfyCell Vessel. The currently in development in-situ perfusion system will enable a complete media exchange and the automatic supply of specific substances to trigger differentiation.
Process Modalities
In-situ Perfusion
Leverage the options for continuous supply of nutrients and media exchange through the (currently in development) perfusion system for optimizing cell density and maximizing yield.
Discover Our Application Studies
Our Advocates
Experience Comfycell for yourself.
Convince yourself of the new generation of bioreactors - short delivery times, attractive financing models, and process experts by your side make getting started as easy as possible for you.
